MBC is generally oestrogen receptor (ER) negative, progesterone receptor (PgR) negative and human epidermal growth factor receptor 2 (HER2) negative, categorized as triple-negative breast carcinoma (TNBC) [2, 3]. Here, ERBB2 is linked to triple-negative breast carcinoma.